Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 230

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Emergence and expansion of SARS-CoV-2 B.1.526 after identification in New York

Open access
Annavajhala, Medini K., Mohri, Hiroshi, Wang, Pengfei, Nair, Manoj, Zucker, Jason E., Sheng, Zizhang, Gomez-Simmonds, Angela, Kelley, Anne L., Tagliavia, Maya, Huang, Yaoxing, Bedford, Trevor, Ho, David D., Uhlemann, Anne-Catrin·2021·Nature

Published version of a preprint

Abstract

SARS-CoV-2 infections have surged across the globe in recent months, concomitant with considerable viral evolution 1–3 . Extensive mutations in the spike protein may threaten the efficacy of vaccines and therapeutic monoclonal antibodies 4 . Two signature spike mutations of concern are E484K, which has a crucial role in the loss of neutralizing activity of antibodies, and N501Y, a driver of rapid worldwide transmission of the B.1.1.7 lineage. Here we report the emergence of the variant lineage B.1.526 (also known as the Iota variant 5 ), which contains E484K, and its rise to dominance in New York City in early 2021. This variant is partially or completely resistant to two therapeutic monoclonal antibodies that are in clinical use and is less susceptible to neutralization by plasma from individuals who had recovered from SARS-CoV-2 infection or serum from vaccinated individuals, posing a modest antigenic challenge. The presence of the B.1.526 lineage has now been reported in all 50 states in the United States and in many other countries. B.1.526 rapidly replaced earlier lineages in New York, with an estimated transmission advantage of 35%. These transmission dynamics, together with the relative antibody resistance of its E484K sub-lineage, are likely to have contributed to the sharp rise and rapid spread of B.1.526. Although SARS-CoV-2 B.1.526 initially outpaced B.1.1.7 in the region, its growth subsequently slowed concurrently with the rise of B.1.1.7 and ensuing variants.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41586-021-03908-2

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Research works printed but not linked: 17

  1. Duchene, S. et al. Temporal signal and the phylodynamic threshold of SARS-CoV-2. Virus Evol. 6, veaa061 (2020). · DOI · Paper page
  2. Iacobucci, G. Covid-19: new UK variant may be linked to increased death rate, early data indicate. BMJ 372, n230 (2021). · DOI · Paper page
  3. Washington, N. L. et al. Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States. Cell 184, 2587–2594.e7 (2021). · DOI · Paper page
  4. Sabino, E. C. et al. Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence. Lancet 397, 452–455 (2021). · DOI · Paper page
  5. Zucman, N., Uhel, F., Descamps, D., Roux, D. & Ricard, J. D. Severe reinfection with South African SARS-CoV-2 variant 501Y.V2: a case report. Clin. Infect. Dis. https://doi.org/10.1093/cid/ciab129 (2021). · DOI
  6. Nonaka, C. K. V. et al. Genomic evidence of SARS-CoV-2 reinfection involving E484K spike mutation, Brazil. Emerg. Infect. Dis. 27, 1522–1524 (2021). · DOI · Paper page
  7. West, A. P., Barnes, C. O., Yang, Z. & Bjorkman, P. J. Detection and characterization of the SARS-CoV-2 lineage B.1.526 in New York. Nat. Commun. 12, 4886 (2021). · DOI
  8. Goudsmit, J., De Ronde, A., Ho, D. D. & Perelson, A. S. Human immunodeficiency virus fitness in vivo: calculations based on a single zidovudine resistance mutation at codon 215 of reverse transcriptase. J. Virol. 70, 5662–5664 (1996). · DOI
  9. Ali, S. T. et al. Serial interval of SARS-CoV-2 was shortened over time by nonpharmaceutical interventions. Science 369, 1106–1109 (2020). · DOI · Paper page
  10. Lasek-Nesselquist, E., Lapierre, P., Schneider, E., George, K. S. & Pata, J. The localized rise of a B.1.526 SARS-CoV-2 variant containing an E484K mutation in New York State. Preprint at https://doi.org/10.1101/2021.02.26.21251868 (2021). · DOI
  11. Smyrlaki, I. et al. Massive and rapid COVID-19 testing is feasible by extraction-free SARS-CoV-2 RT-PCR. Nat. Commun. 11, 4812 (2020). · DOI · Paper page
  12. Quick, J. Artic protocol. Protocols.io https://www.protocols.io/view/ncov-2019-sequencing-protocol-v3-locost-bh42j8ye (2021). · DOI · Paper page
  13. Freed, N., Vlkova, M., Faisal, M. B. & Silander, O. Rapid and inexpensive whole-genome sequencing of SARS-CoV2 using 1200 bp tiled amplicons and Oxford Nanopore rapid barcoding. Biol. Methods Protoc. 5, bpaa014 (2020). · DOI · Paper page
  14. Sagulenko, P., Puller, V. & Neher, R. A. TreeTime: maximum-likelihood phylodynamic analysis. Virus Evol. 4, vex042 (2018). · DOI · Paper page
  15. Shu, Y. & McCauley, J. GISAID: global initiative on sharing all influenza data—from vision to reality. Euro Surveill. 22, 30494 (2017). · DOI · Paper page
  16. Pinto, D. et al. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature 583, 290–295 (2020). · DOI · Paper page
  17. Zost, S. J. et al. Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein. Nat Med 26, 1422–1427 (2020). · DOI · Paper page

Cited by

See all 230

Metadata

Authors
Annavajhala, M. K., Mohri, H., Wang, P., Nair, M., Zucker, J. E., Sheng, Z., Gomez-Simmonds, A., Kelley, A. L., Tagliavia, M., Huang, Y., Bedford, T., Ho, D. D., & Uhlemann, A.-C.
Venue
Nature
Published
2021-08-24
Volume
597
Issue
7878
Pages
703-708
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W3194798235
Cited by
230
References
22
FWCI
15.55
Type
journal article
Language
en
Open access
hybrid
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Emergence and expansion of SARS-CoV-2 B.1.526 after identification in New York. https://app.cochat.ai/papers/10.1038/s41586-021-03908-2
The paper
Annavajhala, M. K., Mohri, H., Wang, P., Nair, M., Zucker, J. E., Sheng, Z., Gomez-Simmonds, A., Kelley, A. L., Tagliavia, M., Huang, Y., Bedford, T., Ho, D. D., & Uhlemann, A.-C. (2021). Emergence and expansion of SARS-CoV-2 B.1.526 after identification in New York. Nature. https://doi.org/10.1038/s41586-021-03908-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.